S. Ball

593 total citations · 1 hit paper
5 papers, 412 citations indexed

About

S. Ball is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Ball has authored 5 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in S. Ball's work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Research Studies (2 papers). S. Ball is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Research Studies (2 papers). S. Ball collaborates with scholars based in United Kingdom, Chile and Hungary. S. Ball's co-authors include Zsuzsanna Szalai, Diana Mendus, Rachel E. Sanborn, Francesco Orlandi, Jerome H. Goldschmidt, Rodolfo Bordoni, Silvia Novello, Manuel Cobo, Makoto Nishio and Tien Hoang and has published in prestigious journals such as Annals of Oncology, Journal of Thoracic Oncology and Hormone Research in Paediatrics.

In The Last Decade

S. Ball

5 papers receiving 408 citations

Hit Papers

Atezolizumab Plus Chemotherapy for First-Line Treatment o... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ball United Kingdom 5 378 304 56 35 20 5 412
Pascale Dubray Longeras France 3 269 0.7× 216 0.7× 46 0.8× 24 0.7× 13 0.7× 3 299
Hai-Yan Tu China 3 241 0.6× 189 0.6× 35 0.6× 26 0.7× 18 0.9× 5 271
Mayank Gandhi United States 6 295 0.8× 241 0.8× 44 0.8× 20 0.6× 19 0.9× 10 326
Junliang Cai United States 9 451 1.2× 397 1.3× 65 1.2× 52 1.5× 52 2.6× 12 534
H.Z. Turna Türkiye 7 326 0.9× 264 0.9× 50 0.9× 50 1.4× 8 0.4× 8 367
Larry Leon United States 8 258 0.7× 232 0.8× 25 0.4× 41 1.2× 28 1.4× 14 316
James Xu United States 5 275 0.7× 117 0.4× 67 1.2× 29 0.8× 61 3.0× 11 332
Susan Stonehouse-Lee United States 4 383 1.0× 171 0.6× 72 1.3× 26 0.7× 35 1.8× 5 412
Joanna Wójcik-Tomaszewska United States 3 225 0.6× 131 0.4× 55 1.0× 18 0.5× 15 0.8× 3 255
Farah Louise Lim United Kingdom 4 249 0.7× 159 0.5× 56 1.0× 24 0.7× 11 0.6× 7 287

Countries citing papers authored by S. Ball

Since Specialization
Citations

This map shows the geographic impact of S. Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ball more than expected).

Fields of papers citing papers by S. Ball

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ball. The network helps show where S. Ball may publish in the future.

Co-authorship network of co-authors of S. Ball

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ball. A scholar is included among the top collaborators of S. Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ball. S. Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Kaul, Sandeep, Christopher Rao, Mehnaz A. Shafi, et al.. (2021). Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?. Clinical Oncology. 34(1). e25–e34. 7 indexed citations
2.
NISHIO, MAKI, Fabrice Barlési, S. Ball, et al.. (2020). 375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC. Annals of Oncology. 31. S1386–S1387. 9 indexed citations
3.
Nishio, Makoto, Fabrice Barlési, Howard West, et al.. (2020). Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial. Journal of Thoracic Oncology. 16(4). 653–664. 290 indexed citations breakdown →
4.
Papadimitrakopoulou, Vassiliki A., Manuel Cobo, Rodolfo Bordoni, et al.. (2018). OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC. Journal of Thoracic Oncology. 13(10). S332–S333. 102 indexed citations
5.
Ball, S., H. F. Johnstone, Simon Bailey, et al.. (2006). Hypercalcaemia in Relapsed Medulloblastoma 8 Years Post-Diagnosis; Evidence to Support PTHrP Production by Medulloblastoma Cells. Hormone Research in Paediatrics. 66(6). 268–272. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026